Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Correction: PP2A inhibition overcomes acquired resistance to HER2 targeted therapy ; volume:22 ; number:1 ; day:30 ; month:10 ; year:2023 ; pages:1-2 ; date:12.2023
Molecular cancer ; 22, Heft 1 (30.10.2023), 1-2, 12.2023
- Urheber
-
McDermott, Martina S. J.
Browne, Brigid C.
Conlon, Neil T.
O’Brien, Neil A.
Slamon, Dennis J.
Henry, Michael
Meleady, Paula
Clynes, Martin
Dowling, Paul
Crown, John
O’Donovan, Norma
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12943-023-01890-z
- URN
-
urn:nbn:de:101:1-2024012409145121989033
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McDermott, Martina S. J.
- Browne, Brigid C.
- Conlon, Neil T.
- O’Brien, Neil A.
- Slamon, Dennis J.
- Henry, Michael
- Meleady, Paula
- Clynes, Martin
- Dowling, Paul
- Crown, John
- O’Donovan, Norma
- SpringerLink (Online service)
Ähnliche Objekte (12)
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
PP2A and tumor radiotherapy
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Targeted therapy for HER2 positive breast cancer
Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
PP2A and tumor radiotherapy
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Targeted therapy for HER2 positive breast cancer
Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer
PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy
Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors
Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy
Suppression of Mig-6 overcomes the acquired EGFR-TKI resistance of lung adenocarcinoma
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
PP2A and tumor radiotherapy
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers
Targeted therapy for HER2 positive breast cancer
Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers